Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrombolysis in Intermediate High Risk Pulmonary Embolism
NCT07374978Completed
- Sponsor
- Ain Shams University
- Start
- Jul 2023
- Primary completion
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of streptokinase and tissue-plasminogen activator in pulmonary embolism (PE) (2 arms), sponsored by Ain Shams University. Primary endpoints: 30-day Mortality and Bleeding Events. Started Jul 2023; status: completed.
02
Drugs
streptokinasetissue-plasminogen activator
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT07374978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07374978.